Collegium Pharmaceutical, Inc.
COLL
$36.27
$1.474.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.13% | -34.03% | -63.69% | -52.95% | 43.68% |
| Total Depreciation and Amortization | 33.65% | 52.72% | 47.32% | 29.97% | 13.34% |
| Total Amortization of Deferred Charges | -11.22% | -16.26% | -28.34% | -31.07% | -30.33% |
| Total Other Non-Cash Items | 100.60% | -42.15% | -28.90% | 17.37% | -66.81% |
| Change in Net Operating Assets | 106.84% | 82.05% | -6,107.14% | -258.79% | -352.99% |
| Cash from Operations | 60.66% | 50.21% | -26.46% | -35.78% | -25.39% |
| Capital Expenditure | -5.33% | -30.10% | -57.17% | -120.63% | -258.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -232.77% | -65.91% | 92.52% | 88.75% | 73.61% |
| Cash from Investing | 77.92% | 81.66% | -388.48% | -214.67% | -306.37% |
| Total Debt Issued | 73.90% | -96.30% | 5,075.16% | 5,459.36% | 34.58% |
| Total Debt Repaid | -107.93% | 80.74% | 1.61% | -50.53% | -1.50% |
| Issuance of Common Stock | -49.04% | -65.83% | -77.62% | -11.15% | 21.67% |
| Repurchase of Common Stock | 52.08% | 21.15% | 52.33% | 13.09% | 5.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 36.11% | -208.60% | -208.60% | -97.13% | -88.30% |
| Cash from Financing | -81.91% | -48.82% | 110.30% | 87.93% | 56.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 208.48% | 154.47% | 67.80% | -165.67% | -324.88% |